Fig. 3.

Decision framework—evidence synthesis eligibility and method selection. *Cope S, Zhang J, Saletan S, Smiechowksi B, et al. A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer. BMC Medicine 2014,12:93. DIC deviance information criterion, FE fixed effects, MAIC matching-adjusted indirect comparisons, ML-NMR multi-level network meta-regression, NMA network meta-analysis, PICOS population, intervention, comparator, outcomes, setting, PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses, RE random effects, SLR systematic literature review